VC  Enso Ventures

http://www.ensoventures.com/





     Office Locations:

745 Fifth Avenue, Suite 510
New York, NY 10151
Phone: 646-696-0056

Get all office locations for this firm with a National Database subscription.
 

Stages:

  • Early


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare
  • Software & Internet

  •  

    Description:

    Enso Ventures is a private investment and project management company that specializes in making selective equity investments in high-technology and bio-tech companies. The firm has portfolio companies throughout Europe, the United States, and Russia.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Andrey Kozlov Partner
    Artem Skubenko Investment Manager
    Edward McGill Financial Controller
    Kim Berknov Partner
    Kirill Mudryy Investment Manager

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      07/20/2017


      NeuroVia


      MA


      $14,000,000


      Series A


     

    Portfolio companies include:


      Cambridge Nanotherm
        web link


      Carbodeon
        web link


      Cavion
        web link


      Cellectar Biosciences
        web link


      Egalet
        web link


      Enso Detego
        web link


      Galera Therapeutics
        web link


      Nanotherm
        web link


      NeuroVia


      Picodeon
        web link


      Pronutria
        web link


      Seres Health
        web link


     

    Recent News: